Which medication might be provided for bronchodilation in Bronchiectasis?

In the management of bronchiectasis, bronchodilation is key to improving airflow and reducing symptoms. The use of aerosolized short-acting beta-agonists (SABAs) and anticholinergics is effective because it addresses bronchial smooth muscle constriction, leading to relaxation of the airways. This combination helps to increase airflow and alleviate wheezing, which are common issues in patients with bronchiectasis due to airway inflammation and obstruction.

Aerosolized medications allow for targeted delivery directly to the lungs, maximizing therapeutic effects while minimizing systemic side effects. Short-acting bronchodilators help provide quick relief during acute symptoms, while anticholinergics can also contribute to sustained bronchodilation. This dual approach is beneficial in managing the obstructive symptoms associated with bronchiectasis.

Other medication options listed do not directly target bronchodilation in the context of bronchiectasis. Oral corticosteroids can reduce inflammation but are not primarily used for immediate bronchodilation. Fenoterol tablets, while a bronchodilator, are usually not the first choice for patients with bronchiectasis since inhaled medications are generally preferred for their rapid action and targeted effect. Oxygen concentrates are used to improve oxygenation in patients with hypoxemia but